Tag Archives: Eli-Lilly-s

FDA Approves New Alzheimer’s Drug, Offering Hope for Slowing Cognitive Decline

US authorities have approved a new Alzheimer’s drug that may slow the disease somewhat, giving patients in the early stages of the incurable, memory-destroying disease a new option. The Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday for mild to early cases of Alzheimer’s dementia. It is only the second drug to be convincingly shown to slow cognitive …

Read More »